Ertugliflozin

Ertugliflozin is a selective sodium-glucose co-transporter 2 (SGLT2) inhibitor used in the treatment of type 2 diabetes mellitus. It helps lower blood glucose levels by preventing glucose reabsorption in the kidneys and promoting its excretion through urine.

As a next-generation oral hypoglycemic agent, Ertugliflozin offers advantages such as weight loss and blood pressure reduction. Our high-purity Ertugliflozin API is manufactured under strict quality standards, suitable for formulation into tablets and other finished dosage forms.

Applications:

• Treatment of Type 2 Diabetes Mellitus

• Combination therapies with metformin, DPP-4 inhibitors

• Research and formulation of SGLT2 inhibitor drugs

Packaging:
1kg, 5kg, or 25kg per drum, with double-layer PE bags

Storage:
Store in a cool, dry place away from light and moisture.